Artificial Insemination Market: By Product Type (Insemination Kits, Home Conception Devices, Accessories), By Procedure Type (Intravaginal Insemination, Intracervical Insemination, Intrauterine Insemination, and Intratubal Insemination), By End User (Hospitals and Clinics, Fertility Centers, Others), and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Artificial Insemination Market size was valued at USD 2.1 billion in 2021, growing at a CAGR of 8.4% during 2022-2028. In order to cure infertility, a procedure known as artificial insemination involves placing semen directly into a woman's womb. The aim of this treatment is to directly inject cleaned sperm into the uterus, cervix, or fallopian tubes using a thin, flexible foley catheter that is inserted through the cervix. This can then lead to pregnancies in women who were previously unable to get pregnant for various reasons. Intrauterine insemination is another name for this procedure in medicine. Due to the increased incidence of infertility problems in both males and females, broad technology breakthroughs in the medical field, and rising healthcare costs across the globe, this market vertical is experiencing profitable growth.

  The Artificial Insemination Market Key Developments:

In 2016, Worthington Industries, collaborated with Intellectual Ventures and launched AIS 3 and AIS 1.5 artificial insemination shield refrigerators holding samples.


Global Artificial Insemination Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Artificial Insemination Market Dynamics

Increase in the prevalence of infertility among the men and women is a major factor surge the growth of artificial insemination market over the forecast years. Increase in the prevalence of infectious diseases, genetic issues, and unhealthy lifestyle are the major factors enhance the infertility among the population. For instance, according to National Survey of Family Growth approximately 15.5% of female population intended to become pregnant are infertile. In addition, as per Center for Disease Control and Prevention, approximately 6.1 Mn female aged between 15-44 years are infertile in USA. Furthermore, development of advanced insemination kits by the market players also surge the market over the forecast timeframe.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2017 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Artificial Insemination Market Segmentation

Product Type
  • Insemination Kits
  • Home Conception Devices
  • Accessories
Procedure Type
  • Intravaginal Insemination
  • Intracervical Insemination
  • Intrauterine Insemination
  • Intratubal Insemination
End User
  • Hospitals and Clinics
  • Fertility Centers
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Vitrolife
  • Genea Limited
  • Kitazato Corporation
  • Bescot Healthcare
  • Church & Dwight Co., Inc.
  • Kate & Duck
  • Insemination Supplies, LLC
  • Zander scientific Inc.
  • Conceivex, Inc.
  • TenderNeeds Fertility
  • Biogenics Inc.
  • Hamilton Throne Ltd.
  • Rinovum Women’s Health, LLC
  • Pride Angel
  • Nikon Instruments Inc.
  • Worthington Industries